Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. 1987

R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara

In a double blind crossover comparison with placebo, the effects of cisapride (10 mg tid for two weeks), a non-antidopaminergic gastrointestinal prokinetic drug, on gastric emptying times and on symptoms were evaluated in 12 patients with chronic idiopathic dyspepsia and gastroparesis. Gastric emptying was studied by a radioisotopic gamma camera technique. The test meal was labelled in the solid component (99mTc-sulphur colloid infiltrated chicken liver). Nine symptoms (nausea, belching, regurgitations, vomiting, postprandial drowsiness, early satiety, epigastric pain or burning, heartburn) were graded weekly on a questionnaire. Cisapride was significantly more effective than placebo in shortening the t1/2 of gastric emptying (p2 = 0.04), but no significant difference was observed between the two treatments with regard to the improvement of total symptom score (p2 = 0.09). No side effects were reported during the study.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010243 Paralysis A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45) Palsy,Plegia,Todd Paralysis,Todd's Paralysis,Palsies,Paralyses,Paralysis, Todd,Paralysis, Todd's,Plegias,Todds Paralysis
D010880 Piperidines A family of hexahydropyridines.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D005260 Female Females
D005746 Gastric Emptying The evacuation of food from the stomach into the duodenum. Emptying, Gastric,Emptyings, Gastric,Gastric Emptyings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
July 1988, Digestive diseases and sciences,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
November 2005, Alimentary pharmacology & therapeutics,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
January 1989, European journal of clinical pharmacology,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
April 1997, Alimentary pharmacology & therapeutics,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
April 1992, Alimentary pharmacology & therapeutics,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
April 1985, Gut,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
May 2000, Alimentary pharmacology & therapeutics,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
July 1991, The Tokai journal of experimental and clinical medicine,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
December 2006, Digestive diseases and sciences,
R Corinaldesi, and V Stanghellini, and C Raiti, and E Rea, and R Salgemini, and L Barbara
November 2023, Neurogastroenterology and motility,
Copied contents to your clipboard!